VC Trends Review.
Études sectorielles, préparées à partir de projets BVM récents.
-
7 août 2026
Q2 2026 VC Trends: Semiconductor Manufacturing Equipment
Selected Q2 financings show capital moving from working prototypes and first shippable systems to production capacity and global support in semiconductor manufacturing equipment.
Lire -
29 juillet 2026
Q2 2026 VC Trends : Geospatial Intelligence for Safety and Risk Mitigation
Selected Q2 financings concentrated around systems that control critical observation data and connect it to operational decisions; safety applications did not independently establish a valuation premium.
Lire -
20 juillet 2026
Q2 2026 VC Trends : Advanced Drug Delivery Systems
Selected Q2 financings favoured delivery systems paired with a defined lead product and executable development path; platform breadth alone did not establish a valuation advantage.
Lire -
17 juillet 2026
Q2 2026 VC Trends : Remote Patient Monitoring
Q2 2026 transactions further distinguish standalone monitoring technologies from platforms combining clinical data, workflow integration, intervention and a credible payment model.
Lire
VC Trends
Q2 2026 VC Trends: Semiconductor Manufacturing ...
Selected Q2 financings show capital moving from working prototypes and first shippable systems to production capacity and global support in semiconductor manufacturing equipment.
Q2 2026 VC Trends: Semiconductor Manufacturing ...
Selected Q2 financings show capital moving from working prototypes and first shippable systems to production capacity and global support in semiconductor manufacturing equipment.
Q2 2026 VC Trends : Geospatial Intelligence for...
Selected Q2 financings concentrated around systems that control critical observation data and connect it to operational decisions; safety applications did not independently establish a valuation premium.
Q2 2026 VC Trends : Geospatial Intelligence for...
Selected Q2 financings concentrated around systems that control critical observation data and connect it to operational decisions; safety applications did not independently establish a valuation premium.
Q2 2026 VC Trends : Advanced Drug Delivery Systems
Selected Q2 financings favoured delivery systems paired with a defined lead product and executable development path; platform breadth alone did not establish a valuation advantage.
Q2 2026 VC Trends : Advanced Drug Delivery Systems
Selected Q2 financings favoured delivery systems paired with a defined lead product and executable development path; platform breadth alone did not establish a valuation advantage.
Q2 2026 VC Trends : Remote Patient Monitoring
Q2 2026 transactions further distinguish standalone monitoring technologies from platforms combining clinical data, workflow integration, intervention and a credible payment model.
Q2 2026 VC Trends : Remote Patient Monitoring
Q2 2026 transactions further distinguish standalone monitoring technologies from platforms combining clinical data, workflow integration, intervention and a credible payment model.